Acceleron news from FierceBiotech
NewsAcceleron doubles space, hires workers
Acceleron Pharma announced plans to increase its headcount by 40 percent and double the size of its administrative, laboratory and manufacturing facilities in Cambridge, MA. "The new space is Read more...
Celgene commits $1.9B to Acceleron
Celgene has agreed to option three development programs at Acceleron and collaborate on the development of its lead bone Read more...
Emerging Drug Developer: Acceleron Acceleron close to partnering on promising bone-building therapy Acceleron Pharmaceuticals is closing in on a licensing deal for its lead therapeutic development program. “We are in discussions Read more... Acceleron garners $31M Series C
Just months after raising its second venture round, Acceleron Pharma has announced a $31 million Series C. Much of that money Read more...
ALSO NOTED: Knopf tapped to run Acceleron; FDA clears Samaritan IND; Wockhardt in hunt for Par; and much more...
> Chutes & Ladders: Acceleron Pharma has named John L. Knopf, Ph.D., as its new CEO. Dr. Knopf, a founder of Acceleron, has served as the executive vice president of corporate Read more...
| Press ReleasesPRESS RELEASE: Acceleron Pharma Completes $31M Series C Financing Acceleron Pharma Completes $31M Series C Financing Top venture syndicate invests to advance expanding pipeline of products that modulate tissue growth and repair Cambridge, Mass. – October 30, Read more... PRESS RELEASE: Acceleron Appoints John Knopf to CEO Spot Acceleron Appoints John Knopf to CEO Spot CAMBRIDGE, MA - September 18, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues Read more... |
Get more Acceleron coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets